Imfinzi® (durvalumab) is the First Immunotherapy to Demonstrate Significant Overall Survival Benefits in Unresectable, Stage III Non-Small Cell Lung Cancer

Tue, 25 Sep 2018 12:58:00 EDT
Click here to read more...

TARA Biosystems' Groundbreaking Biowire™ II Heart-on-a-Chip Platform Earns Acclaim from Frost & Sullivan

Tue, 25 Sep 2018 08:30:00 EDT
Click here to read more...

FSD Pharma Receives First Delivery of Cantabb Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day

Tue, 25 Sep 2018 08:30:00 EDT
Click here to read more...

48North Cannabis Corp. Licenses Colorado's Mother & Clone's Proprietary Cannabis Rapid-Absorption Sublingual Nanospray

Tue, 25 Sep 2018 07:00:00 EDT
Click here to read more...

Tokyo Smoke cannabis retail stores are Coming to Manitoba

Tue, 25 Sep 2018 07:00:00 EDT
Click here to read more...

Inner Spirit Holdings Announces Corporate Spiritleaf Stores in Calgary and Edmonton

Tue, 25 Sep 2018 07:00:00 EDT
Click here to read more...

BELLUS Health Announces Appointment of Clinical Advisory Board

Tue, 25 Sep 2018 07:00:00 EDT
Click here to read more...

Aurora Cannabis Inc. Announces Results for the Fourth Quarter and 2018 Fiscal Year

Mon, 24 Sep 2018 17:32:00 EDT
Click here to read more...

PharmaMar Presents the Overall Survival Data From the Phase I/II Study of lurbinectedin in Combination With Doxorubicin for Relapsed Small Cell Lung Cancer

Mon, 24 Sep 2018 16:46:00 EDT
Click here to read more...

Game Changing Tuberculosis Assay Validated for Illumina's MiSeq® Platform

Mon, 24 Sep 2018 15:38:00 EDT
Click here to read more...